Characterizing the Clinical use of a Novel Video-assisted Dosing Protocol With Secure Medication Dispensers to Reduce Barriers to Opioid Treatment
Authors:
- Marne StothartMSMarne Stothart
- Mallory StunellMSMallory Stunell
- Vanessa Melamede BermanVBVanessa Melamede Berman
- Danielle RylantDRDanielle Rylant
- Melanie HansonMHMelanie Hanson
- 1 May 2022
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Addiction Medicine
- Vol. 16 (3) , 310-316
Abstract
Objectives: Distance and travel costs to opioid treatment programs (OTPs), especially in rural communities, are barriers to treatment for opioid use disorder. Retention rates at 12 months in our OTP are 55% (range 53%–61%).We piloted a novel treatment platform utilizing a video directly observed therapy (VDOT) smartphone app and a secure medication dispenser to support adherence with take-home doses of methadone or buprenorphine while enabling patients to maintain prosocial activities, reduce time and cost of travel, and increase retention. Methods: Participants (n¼58) were adults in a Vermont OTP. Inclusion criteria included travel hardship, access to Wi-Fi or cellular network, and having an iPhone 4S or Android 4.0 or greater. Patients received a dispenser, VDOT app, clinic dispensed medication, counseling, and urine drug testing. Chart reviews assessed VDOT compliance, engagement in prosocial activities, travel costs and time savings, and treatment disposition/retention. Project-associated costs were examined. Results: Of the 15,831 expected videos, 15,581 (98.4%) were received and only 10 (0.063%) showed signs of medication noncompliance with 1 (0.0064%) showing an overt attempt at diversion. About 93% of participants engaged in prosocial activities, travel time and costs were reduced 86%, median cost saved $72 weekly, median travel time saved 5.5 hours weekly and 98% of participants were in treatment 12 months later. Conclusions: VDOT participants using dispensers showed high levels of medication ingestion integrity, had favorable clinical stability, and lower travel time and costs. These findings suggest that using VDOT with dispensers may hold promise as an innovative platform for supporting medication adherence.Keywords
This publication has 28 references indexed in Scilit:
- Bridging waitlist delays with interim buprenorphine treatment: Initial feasibilityAddictive Behaviors, 2015
- Factors Associated with Methadone Treatment Duration: A Cox Regression AnalysisPLOS ONE, 2015
- The Untapped Potential of Office-Based Buprenorphine TreatmentJAMA Psychiatry, 2015
- A Review of Buprenorphine Diversion and MisuseJournal of Addiction Medicine, 2014
- Relationship Between Buprenorphine Adherence and Health Service Utilization and Costs Among Opioid Dependent PatientsJournal of Substance Abuse Treatment, 2014
- The effect of an electronic medicine dispenser on diversion of buprenorphine-naloxone—experience from a medium-sized Finnish cityJournal of Substance Abuse Treatment, 2013
- The Effectiveness of Mobile-Health Technology-Based Health Behaviour Change or Disease Management Interventions for Health Care Consumers: A Systematic ReviewPLOS Medicine, 2013
- Earning “Take-Home” Privileges and Long-Term Outcome in a Methadone Maintenance Treatment ProgramJournal of Addiction Medicine, 2011
- Mortality among opiate users: opioid maintenance therapy, age and causes of deathAddiction, 2009
- Supervised Methadone Consumption: Client Issues and StigmaSubstance Use & Misuse, 2009